Utebzi Tablet, Film Coated
Product Images NDC 0173-0956

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Utebzi (NDC 0173-0956). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glaxosmithkline Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tebipenem Pivoxil Hydrobromide Chemical Structure (Utebzi Spl Graphic 01)

Chemical structure of the active ingredient Tebipenem Pivoxil. The diagram shows the molecular arrangement including functional groups and stereochemistry relevant to the compound.*

FDA Label Image

Utebzi 300 mg 80 Count Carton (Utebzi Spl Graphic 02)

Utebzi (tebipenem pivoxil) 300 mg film-coated oral tablets. The label indicates a package containing 80 tablets, organized as 8 tablets per blister strip and 10 strips per carton. The product is labeled Rx Only and manufactured by GlaxoSmithKline LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.